Company Description
Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally.
The company’s flagship product is the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system.
It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user’s body.
In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data.
It has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems.
The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008.
Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
| Country | United States |
| Founded | 2006 |
| IPO Date | Nov 14, 2013 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 2,650 |
| CEO | John Sheridan |
Contact Details
Address: 12400 High Bluff Drive San Diego, California 92130 United States | |
| Phone | 858 366 6900 |
| Website | tandemdiabetes.com |
Stock Details
| Ticker Symbol | TNDM |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001438133 |
| CUSIP Number | 875372203 |
| ISIN Number | US8753722037 |
| Employer ID | 20-4327508 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| John F. Sheridan | President, Chief Executive Officer and Director |
| Leigh A. Vosseller | Executive Vice President, Chief Financial Officer and Treasurer |
| Susan M. Morrison | Executive Vice President and Chief Administrative Officer |
| Elizabeth Anne Gasser | Executive Vice President and Chief Strategy and Product Officer |
| Mark Novara | Executive Vice President and Chief Commercial Officer |
| Jean-Claude E. Kyrillos | Executive Vice President and Chief Operating Officer |
| Rick A. Carpenter | Chief Technical Officer |
| Shannon M. Hansen J.D. | Executive Vice President, Chief Legal, Privacy and Compliance Officer and Secretary |
| Tom Fox | Chief Human Resources Officer |
| Dr. Jordan Pinsker M.D. | Chief Medical Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 8, 2025 | ARS | Filing |
| Apr 8, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 8, 2025 | DEF 14A | Other definitive proxy statements |
| Feb 26, 2025 | 10-K | Annual Report |
| Feb 26, 2025 | 8-K | Current Report |
| Nov 21, 2024 | 144 | Filing |
| Nov 20, 2024 | 144 | Filing |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 8, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 6, 2024 | 10-Q | Quarterly Report |